These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31150279)

  • 1. Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma.
    Limkin EJ; Blanchard P
    Br J Radiol; 2019 Oct; 92(1102):20190068. PubMed ID: 31150279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The next decade of clinical trials in locoregionally advanced nasopharyngeal carcinoma.
    Peng L; Liu JQ; Chen YP; Ma J
    Br J Radiol; 2019 Oct; 92(1102):20181031. PubMed ID: 31112398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?
    Juarez-Vignon Whaley JJ; Afkhami M; Sampath S; Amini A; Bell D; Villaflor VM
    Curr Treat Options Oncol; 2023 Jul; 24(7):845-866. PubMed ID: 37145382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Nasopharyngeal Carcinoma: Is Adjuvant Therapy Needed?
    Lee VH; Lam KO; Chang AT; Lam TC; Chiang CL; So TH; Choi CW; Lee AW
    J Oncol Pract; 2018 Oct; 14(10):594-602. PubMed ID: 30312564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma.
    Lee AW; Ngan RK; Tung SY; Cheng A; Kwong DL; Lu TX; Chan AT; Chan LL; Yiu H; Ng WT; Wong F; Yuen KT; Yau S; Cheung FY; Chan OS; Choi H; Chappell R
    Cancer; 2015 Apr; 121(8):1328-38. PubMed ID: 25529384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
    Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Li Y; Tang QN; Sun XS; Liang YJ; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    J Natl Compr Canc Netw; 2019 Jun; 17(6):703-710. PubMed ID: 31200353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and controversy for the role of chemotherapy in nasopharyngeal carcinoma.
    Yoshizaki T; Kondo S; Murono S; Endo K; Tsuji A; Nakanishi Y; Nakanishi S; Sugimoto H; Hatano M; Ueno T; Wakisaka N
    Jpn J Clin Oncol; 2015 Mar; 45(3):244-7. PubMed ID: 25583421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Huang CL; Sun ZQ; Guo R; Liu X; Mao YP; Peng H; Tian L; Lin AH; Li L; Shao JY; Sun Y; Ma J; Tang LL
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):355-361. PubMed ID: 30682489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients.
    Kim KY; Le QT; Yom SS; Ng RHW; Chan KCA; Bratman SV; Welch JJ; Divi RL; Petryshyn RA; Conley BA
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):996-1001. PubMed ID: 28721913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
    Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
    Ng WT; Ngan RKC; Kwong DLW; Tung SY; Yuen KT; Kam MKM; Sze HCK; Yiu HHY; Chan LLK; Lung ML; Lee AWM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):630-638. PubMed ID: 29413277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysis.
    Yan M; Kumachev A; Siu LL; Chan KK
    Eur J Cancer; 2015 Aug; 51(12):1570-9. PubMed ID: 26044925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal carcinoma: understanding its molecular biology at a fine scale.
    Paul P; Deka H; Malakar AK; Halder B; Chakraborty S
    Eur J Cancer Prev; 2018 Jan; 27(1):33-41. PubMed ID: 27748661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH
    Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J; Thephamongkhol K
    BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma.
    Chen YP; Chan ATC; Le QT; Blanchard P; Sun Y; Ma J
    Lancet; 2019 Jul; 394(10192):64-80. PubMed ID: 31178151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials in nasopharyngeal carcinoma-past, present and future.
    Xu C; Chen YP; Ma J
    Chin Clin Oncol; 2016 Apr; 5(2):20. PubMed ID: 27121880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.